aTyr has convened a select group of experienced drug discovery leaders to guide our discovery and development of innovative Physiocrine-based medicines. aTyr’s Therapeutic Advisory Board members have extensive drug development expertise in both biotechnology and pharmaceutical company settings. They have repeatedly demonstrated their ability to build high quality, transformational research and development organizations and develop promising research into commercialized therapeutic products.
Restoring fundamental processes